Xin Dong Guo

8.0k citations
150 papers · 6.5k indexed · 2 hit papers · h-index 44

Xin Dong Guo

140 papers receiving 6.4k citations

Hit Papers

Improved pharmacodyna...1352011202620162021100200300400500

Peers

Xin Dong Guo
Comparison fields: 5 of 140
  • Pharmaceutical Science 2.5k
  • Dermatology 1.1k
  • Biomaterials 1.4k
  • Organic Chemistry 1.4k
  • Microbiology 300
Replace Niren Murthy with:
Niren Murthy United States
Andreas G. Schätzlein United Kingdom
Ijeoma F. Uchegbu United Kingdom
Jicheng Yu China
Theerasak Rojanarata Thailand
Jinqiang Wang China
Steven P. Schwendeman United States
Dimitrios A. Lamprou United Kingdom
Antônio Cláudio Tedesco Brazil
Guilan Quan China
Xin Dong Guo relative to Niren Murthy United States Niren Murthy's profile →
Citations per field
00.5×1.5×2.1×
Niren Murthy · 1×
Citations per year

Countries citing papers authored by Xin Dong Guo

Since Specialization
Citations

This map shows the geographic impact of Xin Dong Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Dong Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Dong Guo more than expected).

Fields of papers citing papers by Xin Dong Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Dong Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Dong Guo. The network helps show where Xin Dong Guo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Xin Dong Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xin Dong Guo Line = papers co-authored together Xin Dong Guo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20250
4 20255
5 20251
6 20250
7 20249
8 20247
9 20248
10 202411
11 20230
12 202312
13 202375
14 202319
15 202326
16 201748
17 2016110
18 20121
19 201229
20 200829

About Xin Dong Guo

Xin Dong Guo is a scholar working on Pharmaceutical Science, Dermatology and Biomaterials, having authored 150 papers that have together received 6.5k indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (65 papers), Dermatology and Skin Diseases (29 papers), Advanced Drug Delivery Systems (23 papers), Surfactants and Colloidal Systems (21 papers), Nanoparticle-Based Drug Delivery (21 papers), Lipid Membrane Structure and Behavior (20 papers), Block Copolymer Self-Assembly (17 papers) and Advanced Polymer Synthesis and Characterization (17 papers). The work is most often cited by research in Pharmaceutical Science (2.5k citations), Dermatology (1.1k citations) and Biomaterials (1.4k citations). Xin Dong Guo has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Bo Zhi Chen, Francis C. Szoka, Lijuan Zhang, Xiao Peng Zhang, Dan Zhu, Qi Lei Wang, Yu Qian, Can Yang Zhang, Ze Qiang Zhao and Xuan Jin. Their work appears in journals such as Advanced Materials, Nature Communications and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026